Tracon Raises $14M to Advance Cancer Drug

12:58 EDT 20 Apr 2011 |

San Diego’s Tracon Pharmaceuticals says today it has raised $14 million of a planned $22 million round of venture capital needed to advance development of TRC105, a promising therapeutic that inhibits the growth of new blood vessels that supply tumors. The National Cancer Institute also is supporting the company’s research and development, which includes ongoing [...]

Original Article: Tracon Raises $14M to Advance Cancer Drug


More From BioPortfolio on "Tracon Raises $14M to Advance Cancer Drug"

Quick Search


Relevant Topic

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...